News from connect biopharmaceuticals

A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Making a selection with these dropdown will cause content on this page to change. News listings will update as each option is selected.

Latest

26 Jan, 2021, 13:00 GMT Connect Biopharma Strengthens Leadership Team with Key Hire

Connect Biopharma, a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases...

05 Jan, 2021, 13:00 GMT Connect Biopharma Establishes Scientific Advisory Board Comprised of Clinical Development and Program Indication Experts

Connect Biopharma, a global clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators...

12 Nov, 2020, 13:00 GMT Connect Biopharma Announces Appointment of Karen J. Wilson and Dr. Kleanthis G. Xanthopoulos to Board of Directors

Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators for the...

09 Nov, 2020, 13:00 GMT Connect Biopharma to Present at the Jefferies Virtual London Healthcare Conference on November 17, 2020

Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators for the...

29 Oct, 2020, 11:00 GMT Complete Data from Connect Biopharma's Phase 1b Study of CBP-201 Demonstrate Rapid, Early and Continuous Improvement in Patient Quality of Life and Atopic Dermatitis (AD) Symptoms

Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators for the...

22 Oct, 2020, 11:30 GMT Connect Biopharma to Present Additional Positive Results from the Phase 1b Study of CBP-201 for Patients with Moderate-to-Severe Atopic Dermatitis (AD) at EADV Virtual Meeting

Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators for the...

24 Aug, 2020, 12:00 GMT Connect Biopharma Completes $115 Million Series C Financing to Advance Ongoing Clinical Trials in Atopic Dermatitis and Ulcerative Colitis and Initiate Additional Clinical Programs

Connect Biopharma ("Connect"), a clinical-stage biopharmaceutical company focused on identifying and developing potent and specific immune modulating ...

20 Jul, 2020, 12:00 GMT Connect Biopharma Initiates Phase 2 Clinical Trial of CBP-201 in Adult Patients with Moderate-to-Severe Atopic Dermatitis

Connect Biopharma, a clinical-stage biopharmaceutical company focused on identifying and developing potent and specific immune modulating molecules,...

25 Feb, 2020, 13:00 GMT Connect Biopharma Enhances its Intellectual Property Estate for CBP-307, a Targeted Therapy with Potential in Multiple Autoimmune Diseases, with Patent Issuances in the United States, EU, Japan and Australia

Connect Biopharma, a clinical-stage biopharmaceutical company focused on identifying and developing potent and specific immune modulating molecules...

08 Jan, 2020, 11:00 GMT Connect Biopharma Reports Positive Topline Data from Moderate-to-severe Atopic Dermatitis (AD) Phase 1b Study of CBP-201

Connect Biopharma, a clinical-stage biopharmaceutical company aimed at identifying potent and specific immune modulating molecules faster and more...

06 May, 2019, 09:00 GMT Connect Biopharma Reports Positive Phase 1 Data and Announces Initiation of Phase 1b Study in Patients with Atopic Dermatitis for Novel IL-4Rα Antibody CBP-201

Connect Biopharma today announced that it has successfully completed a phase 1 single ascending dose (SAD) study of its novel IL-4Rα antibody,...

02 Jan, 2019, 19:15 GMT Connect Biopharmaceuticals Completes $55 Million Series B Financing to Accelerate Clinical Development of Novel Immune Modulators

Connect Biopharmaceuticals, a clinical-stage company that discovers and develops novel immune modulators for the treatment of autoimmune diseases and ...

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE
Making a selection with these dropdown will cause content on this page to change. News listings will update as each option is selected.